Raynaud Disease Clinical Trial
Official title:
Phase III Laboratory Study of a Topical Gel Formulation of Nitroglycerin, MQX-503, in the Treatment of Raynaud’s Phenomenon
The purpose of this study is to determine, in comparison to a placebo control, the response
to two dosage strengths of a topical gel formulation of nitroglycerin, MQX-303, in the
determination of finger blood flow and skin temperature in the fingers of patients with
moderate to severe Raynaud's phenomenon, follwoing exposure to cold temperatures.
Blood flow is determined by scanning laser Doppler equipment and skin temperature is
measured using attached thermistor probes. Following baseline measurements, the study gel is
applied, the hand is placed in a cold chamber, and then blood flow and skin temperature are
monitored for the next two hours.
Each patient will receive multiple doses on different days so that each can serve as his/her
own control in interpreting the response.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double-Blind, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01926847 -
Digital Flow Enhancement in Raynaud's Phenomenon With an sGC (Soluble Guanylate Cyclase) Stimulator
|
Phase 2 | |
Completed |
NCT03699436 -
Effectiveness of Electric Stimulation Therapy in Raynaud's Phenomenon
|
N/A | |
Terminated |
NCT02374320 -
Exparel as a Nerve Block for Severe Hand Pain
|
Phase 2/Phase 3 | |
Completed |
NCT00251238 -
Efficacy and Tolerability of Ginkgo Biloba Extract in Patients With Raynaud´s Phenomenon
|
Phase 2 | |
Recruiting |
NCT02183779 -
PORH and Response to Cold in Raynaud's Phenomenon.
|
N/A | |
Active, not recruiting |
NCT00934427 -
Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms
|
Phase 3 | |
Completed |
NCT02506062 -
A Trial of Ischemic Preconditioning in Raynaud's Phenomenon (RP)
|
N/A | |
Terminated |
NCT02642146 -
Treatment of Digital Ulcers in Korean Patients With Systemic Sclerosis: a Prospective Cohort Study
|
||
Completed |
NCT01743612 -
Laser Speckle Contrast Imaging for Cutaneous Microvascular Dysfunction Detection in Systemic Sclerosis.
|
N/A | |
Completed |
NCT03094910 -
Investigation of the Rewarming og the Fingers After Cooling and the Autonomic Nervous System in Raynaud's Phenomenon
|
N/A | |
Recruiting |
NCT02298777 -
Metabolomic Analysis of Systemic Sclerosis
|
||
Completed |
NCT00626665 -
Randomised Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma
|
Phase 3 | |
Completed |
NCT00004786 -
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis
|
Phase 3 | |
Withdrawn |
NCT04898036 -
Phototherapy For Treatment Of Raynaud's Phenomenon
|
N/A | |
Completed |
NCT03027674 -
Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud
|
N/A | |
Terminated |
NCT03869008 -
Potential Benefit for Non Invasive Vagus Nerve Stimulation Using GammaCore in the Treatment of Raynaud's Phenomena.
|
N/A |